JHS SVENDGAARD LABORATORIES
|
|
BOM : 532771     NSE : JHS     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Dec 13,2024 |
Price(EOD): ₹ 23.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Household & Personal Products |
MCap: ₹ 199.88 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
JHS SVENDGAARD LABORATORIES | -4% | -2.5% | -19.2% |
HINDUSTAN UNILEVER | -0.5% | -2.9% | -6.4% |
GODREJ CONSUMER PRODUCTS | -1.5% | -5.5% | 6.4% |
DABUR INDIA | 1.1% | 0.3% | -7.9% |
COLGATEPALMOLIVE (INDIA) | 2.3% | 2.9% | 24.3% |
PROCTER & GAMBLE HYGIENE AND HEALTH CARE | -0.5% | 0.8% | -8.1% |
GILLETTE INDIA | -2.1% | 2.3% | 58.7% |
EMAMI | -4.7% | -14.3% | 19.1% |
JYOTHY LABS | -1.8% | -6.2% | -11.1% |
FUNDAMENTAL ANALYSIS OF JHS SVENDGAARD LABORATORIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JHS SVENDGAARD LABORATORIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-17.11
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -11.69 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 1.18
P/B Calculated based on Book Value of Rs 169.88 Cr
[Latest Year - Mar2024 - Consolidated Results ] 2.49
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 80.13 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 33% 139% |
SHARE PRICE MOMENTUM OF JHS SVENDGAARD LABORATORIES
JHS SVENDGAARD LABORATORIES vs SENSEX
DEBT OF JHS SVENDGAARD LABORATORIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.02 0 0 0.01 |
0.02 0 0 0.01 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF JHS SVENDGAARD LABORATORIES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF JHS SVENDGAARD LABORATORIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-19.62% -143.07% -1136.5% -1540.38% |
3.97% -308.87% -108.76% -1315.36% |
QtrlyTrend |
-6 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
JHS SVENDGAARD LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about JHS SVENDGAARD LABORATORIES
Is JHS SVENDGAARD LABORATORIES good for long term investment?
As on Dec 13,2024, the Fundamentals of JHS SVENDGAARD LABORATORIES look Poor and hence it may not be good for long term investment ! See Financial Performance of JHS SVENDGAARD LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JHS SVENDGAARD LABORATORIES UnderValued or OverValued?
As on Dec 13,2024, JHS SVENDGAARD LABORATORIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JHS SVENDGAARD LABORATORIES ?
As on Dec 13,2024, the Intrinsic Value of JHS SVENDGAARD LABORATORIES is Rs. 13.69 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -9.32
Fair Value [Median EV / Sales Model] : Rs. 17.60
Fair Value [Median Price / Sales Model] : Rs. 9.79
Estimated Median Fair Value of JHS SVENDGAARD LABORATORIES : Rs. 13.69
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.